Search Results "#PrecisionMedicine"

Blogs

arrow_forward View More Results
Proopiomelanocortin Deficiency Treatment Market: How Is Setmelanotide Therapy Becoming the Fastest-Growing Therapeutic Intervention?
Posted by Surbhi on July 24 2026 at 05:41 PM   public
Setmelanotide (IMCIVREE) — the first FDA-approved melanocortin-4 receptor (MC4R) agonist specifically indicated for proopiomelanocortin (POMC) deficiency-associated obesity representing the targe...
Next Generation Bio Therapeutic Market: How Is Cell and Gene Therapy Commercialization Becoming the Fastest-Growing Segment?
Posted by Surbhi on July 23 2026 at 06:02 PM   public
Cell and gene therapy commercialization in next-generation biotherapeutics — the engineered living cell products and genetic medicines (CAR-T, gene editing, stem cell therapies) moving from clini...
Single Cell Genome Sequencing Technology Market: How Is Spatial Genomics Creating the Next Dimension of Cellular Resolution?
Posted by Surbhi on July 14 2026 at 08:20 PM   public
Single-cell genome sequencing — the technologies enabling the analysis of genomic DNA, RNA, and epigenetic modifications at the individual cell level, resolving cellular heterogeneity invisible t...
Streptavidin Kit Market: How Is the Biotin-Streptavidin System Powering the Next Wave of Precision Diagnostics and Therapeutic Development?
Posted by Surbhi on July 14 2026 at 07:22 PM   public
Streptavidin kits — the biotin-binding protein reagent systems enabling high-affinity (Kd ~10^-15 M), versatile detection, purification, and conjugation across immunoassays, flow cytometry, micro...
MEK Inhibitors Market: How Is Neurofibromatosis Type 1 Approval Creating a New Rare-Disease Revenue Stream?
Posted by Surbhi on July 10 2026 at 05:32 PM   public
MEK inhibitors targeting neurofibromatosis type 1-associated plexiform neurofibromas — the oral allosteric MEK1/2 inhibitors selumetinib (Koselugo, AstraZeneca) and mirdametinib (Gomekli, SpringW...
arrow_forward